Sathlokhar has made a significant announcement under Regulation 30 of SEBI Listing Obligations and Disclosure Requirements Regulations, 2015, confirming that the company has successfully bagged a new civil works order. The disclosure was filed with the National Stock Exchange of India Limited (NSE) on 13th October 2025. This latest order marks another milestone in the company’s growing portfolio of contracts and strengthens its presence in the infrastructure and construction sector.

The company informed that it has been awarded an order by Helmier Private Limited, a medical disposables and equipment startup with a focus on anaesthesia, critical care, and rehabilitation robotics. The order relates to the execution of civil works at C4/1A, Vaipur B, Sipcot Medical Devices Park, Oragadam Phase II, Kanchipuram, Chennai, Tamil Nadu. The total order value is estimated at Rs 24.06 crore including GST, and the project is scheduled to be completed before July 2026.

This order comes at a time when Sathlokhar is expanding its order book significantly. The company disclosed that the total work order booked value as of today stands at Rs 1221.98 crore (excluding GST), and these projects are expected to be executed over the next 6 to 10 months. This demonstrates the strong demand and trust the company has garnered in the construction industry, as well as its ability to execute large-scale projects within specified timelines.

The disclosure also highlighted key details as per SEBI requirements. The order from Helmier Pvt Ltd is a domestic contract, with no promoter or related party involvement, ensuring that the agreement does not fall under related party transactions. The nature of the order is purely civil works, and it is expected to be executed in compliance with the agreed terms and conditions.

From an industry perspective, this development is noteworthy as the project is located at Sipcot Medical Devices Park, Oragadam Phase II, which is one of the rapidly growing hubs for medical technology and healthcare infrastructure in India. The collaboration between a construction player like Sathlokhar and a healthcare-focused startup like Helmier Pvt Ltd reflects the integration of infrastructure growth with the emerging medical devices sector. This synergy is aligned with India’s push to enhance domestic healthcare manufacturing capabilities.

For investors and stakeholders, this update holds significant importance. The company’s total order book of Rs 1221.98 crore signals healthy visibility for future revenues, which may positively impact its financial performance in upcoming quarters. The successful execution of such contracts not only enhances the company’s market reputation but also strengthens its competitive positioning against other listed players in the construction space.

The order value of Rs 24.06 crore, though a part of a much larger pipeline, demonstrates the diversity of projects being undertaken by the company. Civil works in specialized sectors such as healthcare facilities demand precision, high-quality construction, and adherence to regulatory standards. By securing this order, Sathlokhar has showcased its ability to deliver in niche and technically demanding sectors, thereby widening its operational footprint.

It is important to note that the company has made this disclosure in compliance with SEBI Circular No. SEBI/HO/CFD/CFD-PoD-1/P/CIR/2023/123 dated 13th July, 2023 and SEBI/HO/CFD/PoD-2/CIR/P/0155 dated 11th November, 2024. These regulations emphasize timely and transparent communication of material events by listed companies. By promptly sharing this order win, Sathlokhar has reaffirmed its commitment to corporate governance and transparent reporting practices.

Looking at the larger picture, Sathlokhar’s growing order book represents the ongoing momentum in India’s construction sector, especially in specialized industries like medical infrastructure development. The Sipcot Medical Devices Park in Chennai is being developed as a world-class hub for medical equipment manufacturing and research, and infrastructure projects in such parks are crucial for creating a robust healthcare ecosystem in India. Sathlokhar’s involvement in such projects highlights its contribution not only to business growth but also to the national objective of strengthening healthcare infrastructure.

Over the next 6 to 10 months, as the company executes its total work order pipeline of Rs 1221.98 crore, stakeholders will be closely monitoring its progress and delivery timelines. Successful and timely execution will be key to building further credibility in the market and enhancing investor confidence. The upcoming quarters may also witness additional contract wins, given the momentum the company is showing in securing orders from varied sectors.

To summarize, the key highlights of this development are:

• Sathlokhar has bagged a Rs 24.06 crore order from Helmier Pvt Ltd for civil works in Chennai, with completion targeted before July 2026.

• The company’s order book now stands at Rs 1221.98 crore excluding GST, to be executed in the next 6–10 months.

• This project is part of the expansion of the Sipcot Medical Devices Park in Oragadam, Chennai, marking Sathlokhar’s growing presence in specialized construction projects.

This disclosure, filed in line with SEBI Listing Regulations, is not only a reflection of Sathlokhar’s business strength but also an indication of the positive growth trajectory in India’s construction sector. For investors, analysts, and market participants, this development is a clear signal of the company’s strengthening fundamentals and operational capabilities.

As the company moves ahead with the execution of this and other contracts, market observers will keep a close watch on financial performance, project completion timelines, and further order wins that could shape Sathlokhar’s growth story in the near future.

Join our Telegram Channel for Latest News and Regular Updates.

Start your Mutual Fund Journey  by Opening Free Account in Asset Plus.

Start your Stock Market Journey and Apply in IPO by Opening Free Demat Account in Choice Broking FinX.